Osteoporosis and Tongue discoloration
Tongue discoloration is found among people with Osteoporosis, especially for people who are female, 60+ old.
The study analyzes which people have Tongue discoloration with Osteoporosis. It is created by eHealthMe based on reports of 133 people who have Osteoporosis from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
133 people who have Osteoporosis and Tongue Discoloration are studied.
What is Osteoporosis?
Osteoporosis (bones weak and more likely to break) is found to be associated with 2,632 drugs and 1,866 conditions by eHealthMe.
What is Tongue discoloration?
Tongue discoloration is found to be associated with 1,260 drugs and 589 conditions by eHealthMe.
Number of Tongue discoloration in Osteoporosis reports submitted per year:
Gender of people who have Osteoporosis and experienced Tongue discoloration *:
Age of people who have Osteoporosis and experienced Tongue discoloration *:
Common co-existing conditions for these people *:
Common drugs taken by these people *:
Common symptoms for these people *:
* Approximation only. Some reports may have incomplete information.
Do you take medications and have Tongue discoloration?Check whether Tongue discoloration is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- Hirschmann S, Gibel A, Tsvelikhovsky I, Lisker A, "Late-Onset Psychosis and Risedronate Treatment for Osteoporosis: A Case Report", Clinical schizophrenia & related psychoses, 2013 May .
- Ko KD, Cho BL, "Risedronate-related Localized Amnesia in an Elderly Patient with Osteoporosis", Journal of the Korean Geriatrics Society, 2012 Dec .
- Lee WY, Sun LM, Lin MC, Liang JA, Chang SN, Sung FC, Muo CH, Kao CH, "A higher dosage of oral alendronate will increase the subsequent cancer risk of osteoporosis patients in Taiwan: a population-based cohort study", PloS one, 2012 Dec .
Treatments, associated drugs and conditions:
- Osteoporosis (269,854 reports)
- Tongue discoloration (4,696 reports)
COVID vaccines that are related to Tongue discoloration:
- Tongue discoloration in Moderna COVID Vaccine
- Tongue discoloration in Pfizer BioNTech Covid Vaccine
- Tongue discoloration in Johnson and Johnson Covid Vaccine
Common drugs associated with Tongue discoloration:
- Aspirin: 248 reports
- Prednisone: 210 reports
- Humira: 171 reports
- Omeprazole: 170 reports
- Methotrexate: 152 reports
- Spiriva: 148 reports
- Metformin: 148 reports
- Enbrel: 135 reports
- Synthroid: 135 reports
- Nexium: 135 reports
All the drugs that are associated with Tongue discoloration:
- Tongue discoloration (1,260 drugs)
Common conditions associated with Tongue discoloration:
- High blood pressure: 252 reports
- Rheumatoid arthritis: 182 reports
- Chronic obstructive pulmonary disease: 181 reports
- Asthma: 168 reports
- High blood cholesterol: 154 reports
- Depression: 141 reports
- Osteoporosis: 133 reports
- Pain: 132 reports
- Multiple sclerosis: 107 reports
- Stress and anxiety: 105 reports
All the conditions that are associated with Tongue discoloration:
- Tongue discoloration (589 conditions)
How the study uses the data?
The study is based on Tongue discoloration and Osteoporosis, and their synonyms.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Tenofovir Disoproxil Fumarate and High Blood Pressure - 8 seconds ago
- Temozolomide and Burkitt Lymphoma - 10 seconds ago
- Desyrel and Hip Joint Replacement - 13 seconds ago
- Cisplatin and Broken Bone - 14 seconds ago
- Inspra and Thrombocytopenia Aggravated - 26 seconds ago
- Tysabri and Superficial Spreading Melanoma Stage Ii - 33 seconds ago
- Lorazepam and Confusion Aggravated - 35 seconds ago
- Vesicare and Foradil drug interaction - 36 seconds ago
- Volmax and High Blood Cholesterol - 42 seconds ago
- Chronic Obstructive Pulmonary Disease and Dyspnea Paroxysmal Nocturnal - 53 seconds ago